General Information


DRAVP ID  DRAVPe01810

Peptide Name   BmKDfsin3

Sequence  GFGCPFNQGKCHRHCRSIRRRGGYCDGFLKQRCVCYRK

Sequence Length  38

UniProt ID  A0A384E0Y8 

Source  Mesobuthus martensii Karsch



Activity Information


Target Organism  HCV

Assay  qPCR

Activity 

  • [Ref.31963532]Hepatitis C virus (HCV): inhibition of viral replication in Huh7.5.1 cells(IC50=3.35±1.1 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.31963532]Human hepatocellular carcinoma Huh-7.5.1 cells: CC50=60.63±1.36 µM.

Binding Target  Not found

Mechanism  BmKDfsin3 is revealed to enter into cells. Using an upstream MyD88 dimerization inhibitor ST2345 or kinase IRAK-1/4 inhibitor I, the inhibition of p38 activation represses HCV replication in vitro.



Structure Information


PDB ID  5XA6 

Predicted Structure Download  DRAVPe01810

Linear/Cyclic  Cyclic

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  Disulfide bonds between Cys4 and Cys25, Cys11 and Cys33, Cys15 and Cys35.

Stereochemistry  L



Physicochemical Information


Formula  C190H299N69O47S6

Absent amino acids  AEMTW

Common amino acids  R

Mass  4494.26

Pl  10

Basic residues  12

Acidic residues  1

Hydrophobic residues  6

Net charge  11

Boman Index  -12439

Hydrophobicity  -92.37

Aliphatic Index  28.16

Half Life 

  •     Mammalian:30 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  3355

Absorbance 280nm  90.68

Polar residues  16



Literature Information


Literature 1

Title   Inhibitory Activity of a Scorpion Defensin BmKDfsin3 against Hepatitis C Virus.

Pubmed ID   31963532

Reference   Antibiotics (Basel). 2020 Jan 17;9(1):33.

Author   Cheng Y, Sun F, Li S, Gao M, Wang L, Sarhan M, Abdel-Rahman MA, Li W, Kwok HF, Wu Y, Cao Z.

DOI   10.3390/antibiotics9010033